CHU Mont-Godinne
Yvoir, Namur, 5530, Belgium
NCT Number: NCT02032069
Primary graft dysfunction, a form of reperfusion pulmonary edema that occurs early after lung transplantation, shares key clinical and pathological features with acute lung injury and its more severe form, the acute respiratory distress syndrome. However, in contrast to acute lung injury/acute respiratory distress syndrome, in which biomarkers in plasma, urine and lung edema fluid have prognostic and pathogenetic value, the role of biomarkers in primary graft dysfunction has been less thoroughly explored. We will try in this study de determine the rule of pneumoproteins in the donor organ on the pulmonary edema in the recipient.
Looking for future studies?
Notify Me5 year–70 year
All sexes
Observational
Yvoir, Namur, 5530, Belgium
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
All the organ donors for lung grafts.
Exclusion criteria
none
Time frame: one year
University Hospital of Mont-Godinne
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05691205
Cardiovascular Diseases, Lung Transplant; Complications
Milan, Italy
View Trial DetailsNCT06159933
Cardiovascular Diseases, Lung Transplant
Padova, Italy
View Trial DetailsNCT01967953
Brain Death, Brain Diseases
Milan, Italy
View Trial DetailsNCT00552357
Cardiovascular Diseases, Lung Transplantation
Philadelphia, Pennsylvania, United States
View Trial Details